Cargando…
Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity
[Image: see text] Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) is a deubiquitylating enzyme that is proposed as a potential therapeutic target in neurodegeneration, cancer, and liver and lung fibrosis. Herein we report the discovery of the most potent and selective UCHL1 probe (IMP-1710) to date...
Autores principales: | Panyain, Nattawadee, Godinat, Aurélien, Lanyon-Hogg, Thomas, Lachiondo-Ortega, Sofía, Will, Edward J., Soudy, Christelle, Mondal, Milon, Mason, Katie, Elkhalifa, Sarah, Smith, Lisa M., Harrigan, Jeanine A., Tate, Edward W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366380/ https://www.ncbi.nlm.nih.gov/pubmed/32579346 http://dx.doi.org/10.1021/jacs.0c04527 |
Ejemplares similares
-
Correction to “Discovery of a Potent and Selective
Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating
Enzyme UCHL1, with Antifibrotic Activity”
por: Panyain, Nattawadee, et al.
Publicado: (2020) -
Activity-based protein profiling reveals deubiquitinase and aldehyde dehydrogenase targets of a cyanopyrrolidine probe
por: Panyain, Nattawadee, et al.
Publicado: (2021) -
Monitoring Target Engagement of Deubiquitylating Enzymes Using Activity Probes: Past, Present, and Future
por: Harrigan, Jeanine, et al.
Publicado: (2016) -
Deubiquitylating enzymes and drug discovery: emerging opportunities
por: Harrigan, Jeanine A., et al.
Publicado: (2017) -
The deubiquitylating enzyme UCHL3 regulates Ku80 retention at sites of DNA damage
por: Nishi, Ryotaro, et al.
Publicado: (2018)